NCT02340780 2023-08-22Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic LeukemiaCanadian Cancer Trials GroupPhase 2 Completed14 enrolled 9 charts
NCT01591421 2023-08-04P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.Canadian Cancer Trials GroupPhase 1/2 Completed22 enrolled